Joanna Baginska

5PUBLICATIONS

75CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 16, 2026

Tumor-Associated Platelets Suppress T-cell Function and Promote Immune Evasion in TNBC via the P-selectin/P-selectin Glycoprotein Ligand 1 Pathway.

|Nov 20, 2025

Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.

Kimberly J Perez, Nora Horick, Joanna Baginksa

|Apr 11, 2025

First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell-Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Patients with Metastatic Melanoma.

F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie

|Sep 30, 2024

A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.

Brandon M Huffman, Osama E Rahma, Kevin Tyan

|Jan 18, 2024

Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.

Candace L Haddox, Michael J Nathenson, Emanuele Mazzola

Pageof 1

Frequent Collaborators

Kathleen Pfaff

F Stephen Hodi

Scott J Rodig

Anita Giobbie-Hurder

Michael P Manos

Allison Nau

Jason L Weirather

Adrian Marino-Enriquez

2 joint publications

Benjamin L Schlechter

1 joint publications

Michael J Nathenson

Frequent Collaborators

Kathleen Pfaff

F Stephen Hodi

Scott J Rodig

Anita Giobbie-Hurder